Matthew C. Coffey
Impact in
- Genetics top 1%
- Virus-based gene therapy research
- Biotechnology top 1%
- Cancer Research and Treatments
Papers in
- Genetics 22
- Virus-based gene therapy research 22
-
- Cancer Research and Treatments 9
- Co-authors
- Patrick W.K. Lee (6 shared papers)James E. Strong (2 shared papers)Peter A. Forsyth (1 shared paper)Alan A. Melcher (8 shared papers)Richard G. Vile (7 shared papers)Kensuke Hirasawa (2 shared papers)Sandra G. Nishikawa (2 shared papers)Kara L. Norman (2 shared papers)
- Journals
- Gene Therapy (3 papers)Annals of Oncology (3 papers)Journal of Biological Chemistry (3 papers)Oncotarget (2 papers)Veterinary and Comparative Oncology (2 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Matthew C. Coffey
29 papers receiving 2.4k citations
Matthew C. Coffey's Hit Papers
Peers
Comparison fields: 5 of 75
- Genetics 1.8k
- Biotechnology 450
- Infectious Diseases 738
- Oncology 1.0k
- Animal Science and Zoology 228
Countries citing papers authored by Matthew C. Coffey
This map shows the geographic impact of Matthew C. Coffey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew C. Coffey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew C. Coffey more than expected).
Fields of papers citing papers by Matthew C. Coffey
This network shows the impact of papers produced by Matthew C. Coffey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew C. Coffey. The network helps show where Matthew C. Coffey may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthew C. Coffey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Reovirus Therapy of Tumors with Activated Ras Pathway Hit paper breakdown → | 1998 | 657 |
| 2 | 2018 | 334 | |
| 3 | 2002 | 147 | |
| 4 | Systemic reovirus therapy of metastatic cancer in immune-competent mice. | 2003 | 131 |
| 5 | 2009 | 126 | |
| 6 | 2009 | 110 | |
| 7 | 2009 | 100 | |
| 8 | 2001 | 91 | |
| 9 | 2008 | 91 | |
| 10 | 2011 | 81 | |
| 11 | 2017 | 78 | |
| 12 | 2015 | 63 | |
| 13 | 2018 | 60 | |
| 14 | 2016 | 57 | |
| 15 | 2009 | 56 | |
| 16 | 2012 | 51 | |
| 17 | 2012 | 48 | |
| 18 | 2014 | 43 | |
| 19 | 1996 | 40 | |
| 20 | 2020 | 29 |
About Matthew C. Coffey
Matthew C. Coffey is a scholar working on Genetics, Biotechnology, Infectious Diseases, Oncology and Molecular Biology, having authored 29 papers that have together received 2.5k indexed citations. Recurring topics across this work include Virus-based gene therapy research (22 papers), Viral gastroenteritis research and epidemiology (14 papers), Cancer Research and Treatments (9 papers), CAR-T cell therapy research (7 papers), RNA Interference and Gene Delivery (4 papers), Heat shock proteins research (3 papers), Animal Virus Infections Studies (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Genetics (1.8k citations), Biotechnology (450 citations), Infectious Diseases (738 citations), Oncology (1.0k citations) and Animal Science and Zoology (228 citations). Matthew C. Coffey has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Patrick W.K. Lee, James E. Strong, Peter A. Forsyth, Alan A. Melcher, Richard G. Vile, Kensuke Hirasawa, Sandra G. Nishikawa, Kara L. Norman, Kevin Joseph Harrington and Elizabeth J. Ilett. Their work appears in journals such as Gene Therapy, Annals of Oncology, Journal of Biological Chemistry, Oncotarget and Veterinary and Comparative Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.